HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE EFFECTS OF HEPARIN THERAPY
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 82 (3), 635-658
- https://doi.org/10.1016/s0025-7125(05)70015-8
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- On the Role of Platelet FcγRIIa Phenotype in Heparin-Induced ThrombocytopeniaThrombosis and Haemostasis, 1995
- Heparin-Induced Thrombocytopenia and ThrombosisNew England Journal of Medicine, 1995
- Heparin-induced thrombocytopenia and heart operation: Management with tedelparinThe Annals of Thoracic Surgery, 1995
- A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometryAmerican Journal of Obstetrics and Gynecology, 1994
- Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparinAmerican Journal of Obstetrics and Gynecology, 1993
- Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]Blood, 1991
- Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172Blood, 1989
- Ancrod: A practical alternative to heparinJournal of Vascular Surgery, 1988
- Immune Endothelial-Cell Injury in Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1987
- Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopeniaArchives of Internal Medicine, 1985